Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

10.0%

1 terminated out of 10 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

80% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (6)
P 2 (1)
P 4 (1)

Trial Status

Completed4
Unknown2
Active Not Recruiting1
Not Yet Recruiting1
Withdrawn1
Terminated1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (10)

Research Network

Activity Timeline